Sniper2L is a high-fidelity Cas9 variant with high activity

被引:20
|
作者
Kim, Young-hoon [1 ,2 ,3 ,4 ]
Kim, Nahye [2 ,5 ]
Okafor, Ikenna [6 ]
Choi, Sungchul [2 ]
Min, Seonwoo [7 ]
Lee, Joonsun [1 ]
Bae, Seung-Min [1 ]
Choi, Keunwoo [1 ]
Choi, Janice [8 ]
Harihar, Vinayak [8 ]
Kim, Youngho [1 ]
Kim, Jin-Soo [9 ,10 ]
Kleinstiver, Benjamin P. [11 ,12 ,13 ]
Lee, Jungjoon K. [1 ]
Ha, Taekjip [8 ,14 ,15 ,16 ]
Kim, Hyongbum Henry [2 ,4 ,5 ,17 ,18 ,19 ,20 ]
机构
[1] Toolgen, Seoul, South Korea
[2] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Grad Program Biomed Engn, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Grad Program Nanosci & Technol, Seoul, South Korea
[5] Yonsei Univ, Grad Sch Med Sci, Brain Korea Project 21, Coll Med, Seoul, South Korea
[6] Johns Hopkins Univ, Dept Biol, Baltimore, MD USA
[7] LG AI Res, Seoul, South Korea
[8] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA
[9] Natl Univ Singapore, Dept Biochem, Singapore, Singapore
[10] Natl Univ Singapore, NUS Synthet Biol Clin & Technol Innovat SynCTI, Singapore, Singapore
[11] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[12] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[13] Harvard Med Sch, Dept Pathol, Boston, MA USA
[14] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA
[15] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[16] Howard Hughes Med Inst, Baltimore, MD 21250 USA
[17] Inst for Basic Sci Korea, Ctr Nanomed, Seoul, South Korea
[18] Yonsei Univ, Yonsei Inst Basic Sci Inst, Seoul, South Korea
[19] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea
[20] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
TARGET CLEAVAGE; DNA; RNA; CRISPR; SPECIFICITY; NUCLEASES; COMPLEX;
D O I
10.1038/s41589-023-01279-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although several high-fidelity SpCas9 variants have been reported, it has been observed that this increased specificity is associated with reduced on-target activity, limiting the applications of the high-fidelity variants when efficient genome editing is required. Here, we developed an improved version of Sniper-Cas9, Sniper2L, which represents an exception to this trade-off trend as it showed higher specificity with retained high activity. We evaluated Sniper2L activities at a large number of target sequences and developed DeepSniper, a deep learning model that can predict the activity of Sniper2L. We also confirmed that Sniper2L can induce highly efficient and specific editing at a large number of target sequences when it is delivered as a ribonucleoprotein complex. Mechanically, the high specificity of Sniper2L originates from its superior ability to avoid unwinding a target DNA containing even a single mismatch. We envision that Sniper2L will be useful when efficient and specific genome editing is required.
引用
收藏
页码:972 / +
页数:31
相关论文
共 50 条
  • [41] Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
    Hu, Johnny H.
    Miller, Shannon M.
    Geurts, Maarten H.
    Tang, Weixin
    Chen, Liwei
    Sun, Ning
    Zeina, Christina M.
    Gao, Xue
    Rees, Holly A.
    Lin, Zhi
    Liu, David R.
    NATURE, 2018, 556 (7699) : 57 - +
  • [42] Dynamics of Target DNA Binding and Cleavage by Staphylococcus aureus Cas9 as Revealed by High-Speed Atomic Force Microscopy
    Puppulin, Leonardo
    Ishikawa, Junichiro
    Sumino, Ayumi
    Marchesi, Arin
    Flechsig, Holger
    Umeda, Kenichi
    Kodera, Noriyuki
    Nishimasu, Hiroshi
    Shibata, Mikihiro
    ACS NANO, 2023, 17 (05) : 4629 - 4641
  • [43] High-efficiency genome editing in plants mediated by a Cas9 gene containing multiple introns
    Gruetzner, Ramona
    Martin, Patrick
    Horn, Claudia
    Mortensen, Samuel
    Cram, Erin J.
    Lee-Parsons, Carolyn W. T.
    Stuttmann, Johannes
    Marillonnet, Sylvestre
    PLANT COMMUNICATIONS, 2021, 2 (02)
  • [44] The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia
    Mihaila, Romeo Gabriel
    Topircean, Diana
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (03): : 249 - 257
  • [45] An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants
    Statkute, Evelina
    Wang, Eddie C. Y.
    Stanton, Richard J.
    HUMAN GENE THERAPY, 2022, 33 (17-18) : 990 - 1001
  • [46] High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9
    Varshney, Gaurav K.
    Pei, Wuhong
    LaFave, Matthew C.
    Idol, Jennifer
    Xu, Lisha
    Gallardo, Viviana
    Carrington, Blake
    Bishop, Kevin
    Jones, MaryPat
    Li, Mingyu
    Harper, Ursula
    Huang, Sunny C.
    Prakash, Anupam
    Chen, Wenbiao
    Sood, Raman
    Ledin, Johan
    Burgess, Shawn M.
    GENOME RESEARCH, 2015, 25 (07) : 1030 - 1042
  • [47] Knock-In of a Large Reporter Gene via the High-Throughput Microinjection of the CRISPR/Cas9 System
    Chen, Shuxun
    Jiao, Yang
    Pan, Fei
    Guan, Zhangyan
    Cheng, Shuk Han
    Sun, Dong
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2022, 69 (08) : 2524 - 2532
  • [48] A High-Throughput Workflow for CRISPR/Cas9 Mediated Combinatorial Promoter Replacements and Phenotype Characterization in Yeast
    Kuivanen, Joosu
    Holmstrom, Sami
    Lehtinen, Birgitta
    Penttila, Merja
    Jantti, Jussi
    BIOTECHNOLOGY JOURNAL, 2018, 13 (09)
  • [49] Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
    Morgens, David W.
    Wainberg, Michael
    Boyle, Evan A.
    Ursu, Oana
    Araya, Carlos L.
    Tsui, C. Kimberly
    Haney, Michael S.
    Hess, Gaelen T.
    Han, Kyuho
    Jeng, Edwin E.
    Li, Amy
    Snyder, Michael P.
    Greenleaf, William J.
    Kundaje, Anshul
    Bassik, Michael C.
    NATURE COMMUNICATIONS, 2017, 8
  • [50] High-resolution in situ analysis of Cas9 germline transcript distributions in gene-drive Anopheles mosquitoes
    Terradas, Gerard
    Hermann, Anita
    James, Anthony A.
    McGinnis, William
    Bier, Ethan
    G3-GENES GENOMES GENETICS, 2022, 12 (01):